Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Long-Term Investments (2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Long-Term Investments for 1 consecutive years, with $4.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments changed N/A to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $4.0 million for FY2025, N/A changed from the prior year.
  • Long-Term Investments hit $4.0 million in Q4 2025 for Cumberland Pharmaceuticals.
  • In the past five years, Long-Term Investments ranged from a high of $4.0 million in Q4 2025 to a low of $4.0 million in Q4 2025.